IND Application WJ 10Aug14 Final
FDA Transmissible Spongiform Encephalopathies Advisory Committee 23 rd Meeting 01 August 2011 Gaithersburg MD Donor Deferral/Ineligibility for Time Spent.
FDA Considerations For Regulation Of Nanomaterial Containing Products Nakissa Sadrieh, Ph.D. Office of Pharmaceutical Science, CDER, FDA.
